| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05c62f2cf821f016678afe25fbcd6ced |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c96fc1cf16a56792aa342cc9b988289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57eb99e6a80c62f466ed2b1fe63e561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb1e2ce0c8277740d77ad30ef87e365 |
| publicationDate |
2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006225317-A |
| titleOfInvention |
Pharmaceutical composition for inhibiting myocardial tissue damage |
| abstract |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition capable of suppressing damage to myocardial tissue after coronary artery occlusion. The present invention provides a pharmaceutical composition for inhibiting damage to myocardial tissue, comprising an aldosterone receptor antagonist. The pharmaceutical composition of the present invention can reduce myocardial infarct size and is particularly useful in the prevention of myocardial infarction. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102011015142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2564854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2564856-A1 |
| priorityDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |